BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3038939)

  • 1. Effect of glutaraldehyde on the antigenicity and infectivity of hepatitis A virus.
    Passagot J; Crance JM; Biziagos E; Laveran H; Agbalika F; Deloince R
    J Virol Methods; 1987 May; 16(1-2):21-8. PubMed ID: 3038939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antiviral substances on hepatitis A virus replication in vitro.
    Biziagos E; Crance JM; Passagot J; Deloince R
    J Med Virol; 1987 May; 22(1):57-66. PubMed ID: 3035080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro.
    Siegl G; Eggers HJ
    J Gen Virol; 1982 Jul; 61 (Pt l)():111-4. PubMed ID: 6288846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis A virus replication in vitro by antiviral compounds.
    Crance JM; Biziagos E; Passagot J; van Cuyck-Gandré H; Deloince R
    J Med Virol; 1990 Jun; 31(2):155-60. PubMed ID: 2167349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
    Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
    Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture.
    Girond S; Crance JM; Van Cuyck-Gandre H; Renaudet J; Deloince R
    Res Virol; 1991; 142(4):261-70. PubMed ID: 1665574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propagation and assay of hepatitis A virus in vitro.
    Siegl G; deChastonay J; Kronauer G
    J Virol Methods; 1984 Aug; 9(1):53-67. PubMed ID: 6094609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology.
    Crance JM; Passagot J; Biziagos E; Deloince R
    J Virol Methods; 1987 Nov; 18(2-3):193-203. PubMed ID: 2828401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.
    Biziagos E; Crance JM; Passagot J; Deloince R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1112-7. PubMed ID: 2168143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alkaline glutaraldehyde on hepatitis B virus antigens.
    Adler-Storthz K; Sehulster LM; Dreesman GR; Hollinger FB; Melnick JL
    Eur J Clin Microbiol; 1983 Aug; 2(4):316-20. PubMed ID: 6414809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
    Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
    Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of hepatitis A virus and poliovirus type 1 in mineral water.
    Biziagos E; Passagot J; Crance JM; Deloince R
    Appl Environ Microbiol; 1988 Nov; 54(11):2705-10. PubMed ID: 2850763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and propagation of hepatitis A virus in hepatoma cell cultures.
    Friedman-Alvermann B; Müller D; Spies K
    Acta Virol; 1985 Dec; 29(6):482-6. PubMed ID: 2869659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectivity titration of the fast-replicating and cytopathic hepatitis A virus strain HM175A.2 by an in situ enzyme immunoassay.
    Yap KL; Lam SK
    J Virol Methods; 1994 Apr; 47(1-2):217-26. PubMed ID: 8051228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propagation of hepatitis A virus in human embryo fibroblasts.
    Gauss-Müller V; Frösner GG; Deinhardt F
    J Med Virol; 1981; 7(3):233-9. PubMed ID: 6270280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical disinfection of hepatitis A virus on environmental surfaces.
    Mbithi JN; Springthorpe VS; Sattar SA
    Appl Environ Microbiol; 1990 Nov; 56(11):3601-4. PubMed ID: 2176450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of hepatitis A virus after ultra-violet inactivation.
    Wang CH; Tschen SY; Flehmig B
    Vaccine; 1995 Jun; 13(9):835-40. PubMed ID: 7483806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and adaptation characteristics of hepatitis A virus in primary African green monkey kidney cells: production of antigen useful for ELISA serology.
    Wang KQ; Nielsen CM; Vestergaard BF
    Intervirology; 1985; 24(2):99-107. PubMed ID: 2997078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of hepatitis A propagation in tissue culture with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
    Widell A; Hansson BG; Nordenfelt E; Oberg B
    J Med Virol; 1988 Apr; 24(4):369-76. PubMed ID: 2835431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adaptation to the cell line PLC/PRF/5 of hepatitis A virus released in the cell culture medium].
    Crance JM; Passagot J; Verwaerde N; Biziagos E; Gandré H; Deloince R
    C R Acad Sci III; 1985; 301(7):361-3. PubMed ID: 2998570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.